- Home
- Publications
- Publication Search
- Publication Details
Title
Modeling precision treatment of breast cancer
Authors
Keywords
Lapatinib, Little Square Support Vector Machine, PIK3CA Mutation, Ixabepilone, Exon Array
Journal
GENOME BIOLOGY
Volume 14, Issue 10, Pages R110
Publisher
Springer Nature
Online
2013-11-01
DOI
10.1186/gb-2013-14-10-r110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of hypoxia on human cancer cell line chemosensitivity
- (2013) Sara Strese et al. BMC CANCER
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Proteomic Classification of Breast Cancer
- (2012) Dalia Kamel et al. CURRENT DRUG TARGETS
- Systematic analysis of genotype-specific drug responses in cancer
- (2012) Nayoung Kim et al. INTERNATIONAL JOURNAL OF CANCER
- PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies HarboringPIK3CAMutations
- (2012) Filip Janku et al. JOURNAL OF CLINICAL ONCOLOGY
- Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations
- (2012) J. G. Greger et al. MOLECULAR CANCER THERAPEUTICS
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Gene expression profiling in breast cancer: classification, prognostication, and prediction
- (2011) Jorge S Reis-Filho et al. LANCET
- A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
- (2011) Luis I Toledo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Subtype and pathway specific responses to anticancer compounds in breast cancer
- (2011) L. M. Heiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2010) J. K. Lee et al. CLINICAL CANCER RESEARCH
- Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer
- (2010) W. Fraser Symmans et al. JOURNAL OF CLINICAL ONCOLOGY
- Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
- (2010) A. Lapuk et al. MOLECULAR CANCER RESEARCH
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines
- (2009) Cornelia Liedtke et al. BREAST CANCER RESEARCH AND TREATMENT
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
- (2008) Yi Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Soft Tissue Sarcoma Cells Are Highly Sensitive to AKT Blockade: A Role for p53-Independent Up-regulation of GADD45
- (2008) Q.-S. Zhu et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started